Investing
Proceeds from sale of investments
Elevance Health Proceeds from sale of investments increased by 16.1% to $3.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.4%, from $4.15B to $3.09B. Over 3 years (FY 2022 to FY 2025), Proceeds from sale of investments shows an upward trend with a 3.6% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2026Apr 22, 2026
How to read this metric
High proceeds indicate active portfolio management or a need to convert investments into cash for operations or acquisitions.
Detailed definition
Represents the cash inflow received from the sale of investment assets. This is a key source of liquidity for insurers,...
Peer comparison
Standard for financial services and insurance firms; peers report this as part of their investing cash flow activities.
Metric ID:
investing_proceedsfromsaleofequityandfixedmaturitysecuritiesHistorical Data
19 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.99B | $1.93B | $3.05B | $4.09B | $2.26B | $2.59B | $2.49B | $2.85B | $2.49B | $2.77B | $4.90B | $2.69B | $4.03B | $4.94B | $4.15B | $3.53B | $2.98B | $2.67B | $3.09B |
| QoQ Change | — | -3.2% | +57.9% | +34.3% | -44.7% | +14.3% | -3.8% | +14.5% | -12.6% | +11.0% | +77.1% | -45.2% | +49.9% | +22.6% | -15.9% | -14.9% | -15.8% | -10.4% | +16.1% |
| YoY Change | — | — | — | — | +13.4% | +34.0% | -18.3% | -30.4% | +10.1% | +7.0% | +96.8% | -5.8% | +61.7% | +78.5% | -15.3% | +31.5% | -26.1% | -46.0% | -25.4% |
Range$1.93B – $4.94B
CAGR+10.3%
Avg YoY Growth+11.0%
Median YoY Growth+7.0%
Proceeds from sale of investments at Other Companies
Frequently Asked Questions
- What is Elevance Health's proceeds from sale of investments?
- Elevance Health (ELV) reported proceeds from sale of investments of $3.09B in Q1 2026.
- How has Elevance Health's proceeds from sale of investments changed year-over-year?
- Elevance Health's proceeds from sale of investments decreased by 25.4% year-over-year, from $4.15B to $3.09B.
- What is the long-term trend for Elevance Health's proceeds from sale of investments?
- Over 3 years (2022 to 2025), Elevance Health's proceeds from sale of investments has grown at a 3.6% compound annual growth rate (CAGR), from $11.99B to $13.32B.
- What does proceeds from sale of investments mean?
- The cash received from selling investment securities.